Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · 2024
DOI: 10.1089/mab.2024.0016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2024. Verfasst von Tsukasa Osaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Patho-Biochemistry and Patho-Biology, School of Medicine, Yamagata University, Yamagata, Japan. Hauptthemen laut MEDLINE: Epitope Mapping, Antibodies, Monoclonal, Factor XIII. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Coagulation factor XIII (FXIII) is an enzyme that strengthens hemostatic clots, and its deficiency can cause life-threatening bleeding. We immunized mice with human plasma-derived FXIII to generate monoclonal antibodies (mAbs) against the B subunit (FXIII-B), which stabilizes the A subunit (FXIII-A) of FXIII, and analyzed their properties. The epitopes of the seven mouse antihuman FXIII-B mAbs obtained were found to be the 3rd, 5th, 6th, 9th, and 10th Sushi domains. One of these mAbs, mAb 5-6C, recognized the 10th Sushi domain and inhibited the fibrin cross-linking reaction without affecting the amine incorporation activity of FXIII. We previously reported that the 10th Sushi domain is the site where FXIII-B binds to fibrin and functions to bring FXIII-A closer to the substrate fibrin. Except for mAb 5-6C, mouse mAbs with high yields were used to measure the amount of FXIII-B antigen by an immunochromatography test (ICT), which showed a high correlation with enzyme-linked immunosorbent assay-obtained results. In addition, we developed a prototype ICT to detect anti-FXIII-B autoantibodies using mAb 1-3C, which showed good results in measuring the amount of FXIII-B antigen. Thus, mouse mAbs may be useful for clinical applications. mAb 5-6C targeting the 10th Sushi domain may also be useful for inhibiting thrombosis progression when humanized as antibody medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Patho-Biochemistry and Patho-Biology, School of Medicine, Yamagata University, Yamagata, Japan.
- The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies Supported by the Japanese Ministry of Health, Labor and Welfare (MHLW), Yamagata University School of Medicine, Yam…
- Department of Public Health and Hygiene, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
- Q-may Laboratory Corporation, Oita, Japan.
Zitieren
APA
Osaki, T., Magari, Y., Souri, M., & Ichinose, A. (2024). Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. https://doi.org/10.1089/mab.2024.0016
Vancouver
Osaki T, Magari Y, Souri M, Ichinose A. Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2024. doi:10.1089/mab.2024.0016
BibTeX
@article{Osaki2024,
author = {Osaki, Tsukasa and Magari, Yasuo and Souri, Masayoshi and Ichinose, Akitada},
title = {Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies},
journal = {Monoclonal Antibodies in Immunodiagnosis and Immunotherapy},
year = {2024},
doi = {10.1089/mab.2024.0016}
}
EUVIMED